Cargando…
A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365451/ https://www.ncbi.nlm.nih.gov/pubmed/32510874 http://dx.doi.org/10.1002/cac2.12066 |
| _version_ | 1783560037763907584 |
|---|---|
| author | Huang, Tuxiong Yang, Jiao Liu, Beilei Fu, Li |
| author_facet | Huang, Tuxiong Yang, Jiao Liu, Beilei Fu, Li |
| author_sort | Huang, Tuxiong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7365451 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73654512020-07-20 A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy Huang, Tuxiong Yang, Jiao Liu, Beilei Fu, Li Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2020-06-08 /pmc/articles/PMC7365451/ /pubmed/32510874 http://dx.doi.org/10.1002/cac2.12066 Text en © 2020 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Huang, Tuxiong Yang, Jiao Liu, Beilei Fu, Li A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy |
| title | A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy |
| title_full | A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy |
| title_fullStr | A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy |
| title_full_unstemmed | A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy |
| title_short | A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy |
| title_sort | new mouse esophageal cancer cell line (mec25)‐derived pre‐clinical syngeneic tumor model for immunotherapy |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365451/ https://www.ncbi.nlm.nih.gov/pubmed/32510874 http://dx.doi.org/10.1002/cac2.12066 |
| work_keys_str_mv | AT huangtuxiong anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy AT yangjiao anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy AT liubeilei anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy AT fuli anewmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy AT huangtuxiong newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy AT yangjiao newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy AT liubeilei newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy AT fuli newmouseesophagealcancercelllinemec25derivedpreclinicalsyngeneictumormodelforimmunotherapy |